^
BIOMARKER:
CDKN2A deletion
i
Other names: CDKN2A, ARF, CDK4I, CDKN2, CMM2, INK4, INK4a, MLM, MTS1, p14, p14ARF, p16, p16INK4a, p19, p19Arf, Cyclin-dependent kinase inhibitor 2A
Entrez ID:
Related biomarkers:
CDKN2A deletion
B Acute Lymphoblastic Leukemia
blinatumomab
Sensitive
:
C3
CDKN2A deletion
Mantle Cell Lymphoma
ibrutinib
Resistant
:
C3
CDKN2A deletion
ALL
blinatumomab
Sensitive
:
C3
CDKN2A deletion
Melanoma
Immunotherapy
Resistant
:
C3
CDKN2A deletion
Gallbladder Cancer
palbociclib
Resistant
:
C3
CDKN2A deletion
Glioma
vincristine + lomustine + procarbazine hydrochloride
Resistant
:
C3
CDKN2A deletion
HCC
Immunotherapy
Sensitive
:
C3
CDKN2A deletion
Melanoma
palbociclib
Sensitive
:
C3
CDKN2A deletion
Pancreatic Cancer
palbociclib
Resistant
:
C3
CDKN2A deletion
Gastric Adenocarcinoma
Immunotherapy
Resistant
:
C3
CDKN2A deletion
Prolymphocytic Leukemia
alemtuzumab
Resistant
:
C4
CDKN2A deletion
Estrogen Receptor Positive Breast Cancer
palbociclib + SNS-510
Sensitive
:
D
CDKN2A deletion
Estrogen Receptor Positive Breast Cancer
ribociclib + SNS-510
Sensitive
:
D
CDKN2A deletion
Ewing Sarcoma
ASP7487
Sensitive
:
D
CDKN2A deletion
Ewing Sarcoma
palbociclib
Sensitive
:
D
CDKN2A deletion
RCC
temsirolimus
Sensitive
:
D
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our